This is a copy of the July 21st edition of our weekly Newsletter, which we have been publishing since October 2015. Friends, Almost $2 billion worth of capital is...
TORONTO, July 18, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction,...
TORONTO, July 16, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction,...
After a 54.9% gain in Q1, the Canadian Cannabis LP Index gave up a lot of ground in Q2, including a 8.4% decline in June to 894.07: The index remains substantially...
TORONTO, June 27, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction,...
TORONTO, June 24, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”), a leader in specialized, research-driven cannabis extraction and...
This is a copy of the June 23rd edition of our weekly Newsletter, which we have been publishing since October 2015. Friends, Almost a year ago, Tilray took off...
MediPharm Labs and Ace Valley Enter Vape Oil White Label Deal TORONTO, June 19, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs”...
TORONTO, June 18, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction,...
TORONTO, June 17, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”), a leader in specialized, research-driven cannabis extraction and...
After a 54.9% gain in Q1, the Canadian Cannabis LP Index backtracked marginally in April and then fell sharply in May, declining 9.7% to 976.56: The index remains substantially below the all-time...
After a 57.4% rebound in Q1 followed by a narrow decline in April, Cannabis stocks, as measured by the Global Cannabis Stock Index, gave up substantial ground in May, declining...
This is a copy of the June 2nd edition of our weekly Newsletter, which we have been publishing since October 2015. Friends, The accountants at MNP must be enjoying...
MediPharm Labs Announces $60 Million Bought Deal Equity Financing TORONTO, May 28, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”),...
New York City Icahn School of Medicine at Mount Sinai and Renowned Global Researcher Dr. Hurd, Select MediPharm Labs to Support 500 Patient Major Clinical Study and “CBD International...
MediPharm Labs Australia Awarded Cannabis Manufacturing Licence From Office of Drug Control – Establishes Asia-Pacific Foothold TORONTO, May 21, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSXV: LABS) (OTCQX:...
The Public Cannabis Company Revenue Tracker, managed by New Cannabis Ventures, ranks the top revenue producing cannabis stocks that generate industry sales of more than US$5.0 million per quarter. This...
Emerald’s ultra-pure SYNC 25 CBD oil fills significant need in BC’s recreational marketplace, offering a non-THC, smoke-free alternative VANCOUVER, British Columbia, May 17, 2019 (GLOBE NEWSWIRE) — Emerald Health...
Financing to Support Accelerated Growth TORONTO, May 15, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs”) a leader in specialized, research-driven cannabis extraction and cannabinoid...
Cronos Group and MediPharm Labs Enter $30 Million Multi-Year Private Label Cannabis Concentrate Supply Agreement with Potential to Increase to $60 Million Cronos Group and MediPharm Labs Enter Additional...
This is a copy of the May 12th edition of our weekly Newsletter, which we have been publishing since October 2015. Friends, “The next Tilray”. This was a phrase...
MediPharm Labs Announces Q1 2019 Revenue of $22 Million and Adjusted EBITDA of $4.3 Million TORONTO, May 10, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF)...
After a 57.4% rebound in Q1, Cannabis stocks, as measured by the Global Cannabis Stock Index, gave up some ground in April, declining 1.5%: The index, which had 64 qualifying...
After a 54.9% gain in Q1, the Canadian Cannabis LP Index backtracked marginally in April, declining 0.9% to 1081.95: The index remains substantially below the all-time closing high of 1289.57 on October...
TORONTO, May 02, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction,...
